# OnCo record slv-324 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/slv-324/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "slv-324" ;
  schema:name "SLV-324"@en ;
  schema:description "SLV-324 is an experimental antibody-drug conjugate from Solve Therapeutics, in phase 1 trials for metastatic solid tumours."@en ;
  schema:url <https://onco.cc/drugs/slv-324/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://solvetx.com/>, <https://clinicaltrials.gov/study/NCT07108114>, <https://clinicaltrials.gov/search?intr=SLV-324> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Antibody-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/solve-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07108114/> .